CD34 and Miyoshi myopathy: In a Phase II study of thalidomide + dexamethasone combination therapy for MM patients, stem cell collection was performed after induction therapy for 59 patients, with an average CD34+ stem cell count of 7.10×106/kg (P>0.05), achieving the target number of stem cells required for transplantation (21).